January 15, 2025 - 22:31

In August, Sudeshna Roy, PhD, officially began her role as an associate professor at the University of Tennessee Health Science Center's College of Pharmacy. This transition marks an exciting new chapter for the institution as Dr. Roy brings with her a wealth of knowledge and expertise in molecular architecture.
Relocating to the fifth floor of the College of Pharmacy building, Dr. Roy is accompanied by a postdoctoral scholar and five doctoral students, all of whom are poised to contribute to groundbreaking research. The new team is equipped with an impressive array of over 2,000 chemicals, which will support their innovative projects and studies in the field of pharmacy and drug development.
Dr. Roy's research aims to explore and design novel molecular structures that can lead to advancements in therapeutic agents. Her arrival is anticipated to enhance the academic environment and foster collaboration within the College, ultimately benefiting students and the broader community.
December 15, 2025 - 04:17
Cassidy Optimistic About Bipartisan Deal on ACA Subsidies by Year-EndSenator Bill Cassidy (R-La.) shared a hopeful outlook on the potential for a bipartisan agreement aimed at extending enhanced Affordable Care Act (ACA) subsidies for specific Americans. Speaking on...
December 14, 2025 - 05:37
Senate's Health Care Votes Fall Short: Key Points to ConsiderThe Senate this week failed to pass dueling bills from Republicans and Democrats aimed at addressing a looming spike in health insurance costs for individuals purchasing Affordable Care Act (ACA)...
December 13, 2025 - 06:07
Unveiling Inspiring Tales of Marathon Runners at the Health and Fitness ExpoDiscover the stories and excitement as runners gather at the Health and Fitness Expo for the marathon weekend. This vibrant event brings together athletes from all walks of life, each with their...
December 12, 2025 - 23:33
Health Experts Criticize Potential High-Level Warnings for COVID VaccinesThe FDA is reportedly contemplating the introduction of high-level warning labels for COVID vaccines, a decision that has sparked significant concern among health experts. Many professionals in the...